The next revolution in wearable technology isn't just about artificial intelligence. It's about human intelligence.
Meta is betting billions on a revolutionary idea: a computer you wear on your face.
Google, Samsung, Warby Parker, and others are joining the race.
Global shipments of AI glasses reached 8.7 million units in 2025, more than quadrupling in a single year.
But while technology giants are racing to make glasses smarter, we're pioneering a new revolution focused on making people smarter.
Upgrade Your Brain.
Our patent-pending MemorySPEX uses liquid-crystal lenses to deliver 40 Hz gamma stimulation, backed by published research into reducing harmful brain plaque, increasing cerebral blood flow, and improving cognitive performance.
Don't just take our word for it.
We won Stanford's Chairman's Choice Award, competing with startups from around the world.
Our five physician investors/advisors scrutinized the science before investing. Dr. Jay Salimath compiled an extensive review addressing their toughest questions.
All five invested.
READ THE SUPPORTING RESEARCH & DOCTOR FAQs
We're raising a $3M seed round to pioneer a new health category with our wearable tech MemorySPEX, NeuroWellness™, bringing cutting-edge neuroscience into an accessible consumer product designed to supercharge cognitive performance—as easy as putting on a pair of glasses.
Our strategy is to enter the $14 billion annual brain-health supplement market, then conduct a clinical trial to evaluate MemorySPEX for the treatment of Alzheimer's disease. Cognito Therapeutics has already raised $233 million to advance 40 Hz stimulation, demonstrating substantial investor commitment to this emerging field.
The Opportunity Is Now.
While Meta was making computer glasses, we were pioneering enhanced cognitive performance.
And today, the pieces are coming together:
Major retailer onboarding is underway for our initial 20-store test. Our financial model projects a $1.7 billion exit scenario with distribution in just 2,000 of this retailer's 9,000 stores—before Alzheimer's revenues.
Proven entrepreneurial leadership: I've done this before, launching my first product into 250 Saks Inc. stores in just two months, as chronicled in my bestselling book, MOMMY MILLIONAIRE.
Experienced manufacturing and technology leadership, backed by five physician investors/advisors, is preparing MemorySPEX for commercialization.
Multiple venture firms are in our investment pipeline as we target November 20 to close our $3 million seed round.
The early investment window in AI glasses has given way to a crowded race among technology giants. But the opportunity to pioneer what wearable technology can do for the human brain is just opening.
We intend to lead it. Will you join us?
SCHEDULE AN INVESTOR CONVERSATION
Excited about the future!
Kim Lavine
Founder & CEO
Hypersence, Inc. | MemorySPEX™